Blue Star Q2 FY27 Earnings Call — Analysis (NSE: BLUESTARCO)
Blue Star delivered 21% revenue growth in Q2FY27 driven by room ACs and data center MEP demand, while targeting a 6.5% Unitary Products margin for FY27 via product cost optimization and price hikes.
Result quality: stable — Results context unavailable. Management sentiment: optimistic.
The take
Q2FY27 Segment 1 Revenue (EMP & Commercial AC) ₹1,936 Cr ( +16.3% YoY ) . Guidance raised . But walked back — Strategic pivot to DCs and factories .
Results
Consolidated revenue grew 21% YoY with operating profit up 10.5% YoY, though segment margins remained compressed across cooling products due to raw material inflation.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Segment 1 Revenue (EMP & Commercial AC) | ₹1,936 Cr | +16.3% | yoy · Q2FY27 |
| Segment 1 Result (EBIT) | ₹133 Cr | -9.5% | yoy · Q2FY27 |
| Segment 2 Revenue (Unitary Products) | ₹898 Cr | +29.4% | yoy · Q2FY27 |
| Segment 2 Result (EBIT) | ₹21 Cr | -51.2% | yoy · Q2FY27 |
| Segment 3 Revenue (PEIS) | ₹97 Cr | +51.0% | yoy · Q2FY27 |
| Segment 3 Result (EBIT) | ₹23 Cr | +271.0% | yoy · Q2FY27 |
| Carried Forward Order Book | ₹7,229 Cr | point_in_time · Q2FY27 · Sep-26 | |
| Net Cash Position | ₹289 Cr | point_in_time · Q2FY27 · Sep-26 |
Guidance
Management maintained its target of reaching at least a 6.5% EBIT margin in Unitary Products for FY27, backed by ~25% RAC revenue growth and capex capped at ₹300 Cr.
Key themes
Margin recovery via product rejig and data centers
Operational commentary
- RAC primary sales grew ~42% in Q2 standalone, outperforming estimated industry growth of 35-40% on extended summer weather and pre-festive channel stocking.
- Defocusing from infrastructure EPC contracts (railway electrification, water, substations) due to execution delays and cost overruns; pivoting resources to high-margin Data Centers and Factory projects.
- Data center MEP market ordering estimated at ₹10,000-12,500 Cr this fiscal year; company holds ~₹2,000 Cr in DC orders with high cash flow visibility and shorter 8-9 month project cycles.
- Divested MedTech business for ₹35.6 Cr on August 31, 2026, relieving the company of warranty obligations and resulting in provision write-backs.
- Evaluating higher outsourcing of entry-level RAC SKUs from ~15% to up to ~30% as part of the Total Competitiveness Management cost-reduction drive.
- Commercial refrigeration demand seeing initial signs of OEM revival, though facing persistent ~24-25% cumulative input cost inflation.
Analyst Q&A
Q. Whether the company is confident in delivering 8%+ Unitary Products margin in H2 to achieve the 6.5% full-year target.
Acknowledged it is a tough task requiring demand to hold, successful execution of value engineering/TCM, and realization of the 5% price hike across the trade.
Q. Inquiry regarding pricing discipline among peer brands and industry leaders.
Stated there is no expectation of peer pricing discipline given industry capacity is 1.7x to 2.0x of demand, meaning aggressive market share battles will continue.
Q. Rationale behind the sharp 57% YoY increase in depreciation and amortization.
Clarified that the increase stems from amortizing capitalized R&D/product development expenses as well as lease depreciation for new offices and warehouses under Ind AS 116.
Q. Whether Blue Star plans to address US data center cooling or liquid cooling market opportunities.
Clarified that international EPC contracting is not viable, US chiller turf is dominated by MNCs, and liquid cooling CDU technology is currently not in-house though partnerships are open.
Research and educational content only. Not investment advice.